Evotec receives EUR2m milestone payment from Boehringer
The multi-target drug discovery alliance was originally signed in 2004 for the co-identification and co-development of preclinical development candidates targeting various disease areas including CNS, inflammation, cardiometabolic and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.